Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, ...

Medicare will expand coverage for GLP-1 drugs. Here's how this new development will affect you if you are on Medicare ...

GLP-1 weight-loss and diabetes drugs may have a future role in cancer prevention and treatment, according to new research highlighted by Citi ahead of the 2026 American Society of Clinical Oncology ...

New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and ...

That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose ...

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need to know before July 2026.

Certain tortillas are now being marketed as ‘GLP-1 friendly.’ What does that even mean? - While a ‘GLP-1 friendly’ label may ...

India, May 31 -- Samsung Electronics and Massachusetts General Hospital (MGH) Diabetes Research Center (DRC) today jointly ...

GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are calling for more research. Reading time 2 minutes Every drug has its risks, no ...